Search research articles
Contact Us
Filters
Showing results (11-20 of 31) with videos related to
Page
of 4
Sort By:
American Journal of Hematology
|
July 27, 2007
Chromosome aberrations in a series of 120 multiple myeloma cases with abnormal karyotypes
Anwar N Mohamed, Gail Bentley, Michelle L Bonnett, et al.
Journal of Cancer Research and Clinical Oncology
|
April 5, 2016
Hematologic malignancies: newer strategies to counter the BCL-2 protein
Abdul Shukkur Ebrahim, Hussam Sabbagh, Allison Liddane, et al.
Molecular Cancer Therapeutics
|
January 7, 2004
Genistein sensitizes diffuse large cell lymphoma to CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) chemotherapy
Ramzi M Mohammad, Ayad Al-Katib, Amro Aboukameel, et al.
Case Reports in Pulmonology
|
February 27, 2019
Lymphomatoid Granulomatosis in a Patient with Chronic Lymphocytic Leukemia and Rapidly Progressing Peribronchovascular Pulmonary Infiltrates
Shahab Rezvani, Marie Tominna, Sayf Al-Katib, et al.
Case Reports in Cardiology
|
January 6, 2017
Primary Cardiac Lymphoma: Lessons Learned from a Long Survivor
Baljit Singh, Randy Ip, Ahmed Ibrahim Al-Rajjal, et al.
Molecular Cancer Therapeutics
|
January 20, 2005
Preclinical studies of a nonpeptidic small-molecule inhibitor of Bcl-2 and Bcl-X(L) [(-)-gossypol] against diffuse large cell lymphoma
Ramzi M Mohammad, Shaomeng Wang, Amro Aboukameel, et al.
Journal of Immunological Methods
|
March 22, 2005
Sheep red blood cells armed with anti-CD20 single-chain variable fragments (scFvs) fused to a glycosylphosphatidylinositol (GPI) anchor: a strategy to target CD20-positive tumor cells
Nayera Hamdy, Anton Scott Goustin, Jean-Paul Desaulniers, et al.
Oncotarget
|
June 11, 2016
PNT2258, a novel deoxyribonucleic acid inhibitor, induces cell cycle arrest and apoptosis via a distinct mechanism of action: a new class of drug for non-Hodgkin's lymphoma
Abdul Shukkur Ebrahim, Mustapha Kandouz, Allison Liddane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2002
Bcl-2 antisense oligonucleotides are effective against systemic but not central nervous system disease in severe combined immunodeficient mice bearing human t(14;18) follicular lymphoma
Ramzi Mohammad, Yousif Abubakr, Maria Dan, et al.
Molecular and Cellular Biology
|
August 27, 2014
Genomic uracil homeostasis during normal B cell maturation and loss of this balance during B cell cancer development
Sophia Shalhout, Dania Haddad, Angela Sosin, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 31) with videos related to
Sort By:
Page
of 4
American Journal of Hematology
|
July 27, 2007
Chromosome aberrations in a series of 120 multiple myeloma cases with abnormal karyotypes
Anwar N Mohamed, Gail Bentley, Michelle L Bonnett, et al.
Journal of Cancer Research and Clinical Oncology
|
April 5, 2016
Hematologic malignancies: newer strategies to counter the BCL-2 protein
Abdul Shukkur Ebrahim, Hussam Sabbagh, Allison Liddane, et al.
Molecular Cancer Therapeutics
|
January 7, 2004
Genistein sensitizes diffuse large cell lymphoma to CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) chemotherapy
Ramzi M Mohammad, Ayad Al-Katib, Amro Aboukameel, et al.
Case Reports in Pulmonology
|
February 27, 2019
Lymphomatoid Granulomatosis in a Patient with Chronic Lymphocytic Leukemia and Rapidly Progressing Peribronchovascular Pulmonary Infiltrates
Shahab Rezvani, Marie Tominna, Sayf Al-Katib, et al.
Case Reports in Cardiology
|
January 6, 2017
Primary Cardiac Lymphoma: Lessons Learned from a Long Survivor
Baljit Singh, Randy Ip, Ahmed Ibrahim Al-Rajjal, et al.
Molecular Cancer Therapeutics
|
January 20, 2005
Preclinical studies of a nonpeptidic small-molecule inhibitor of Bcl-2 and Bcl-X(L) [(-)-gossypol] against diffuse large cell lymphoma
Ramzi M Mohammad, Shaomeng Wang, Amro Aboukameel, et al.
Journal of Immunological Methods
|
March 22, 2005
Sheep red blood cells armed with anti-CD20 single-chain variable fragments (scFvs) fused to a glycosylphosphatidylinositol (GPI) anchor: a strategy to target CD20-positive tumor cells
Nayera Hamdy, Anton Scott Goustin, Jean-Paul Desaulniers, et al.
Oncotarget
|
June 11, 2016
PNT2258, a novel deoxyribonucleic acid inhibitor, induces cell cycle arrest and apoptosis via a distinct mechanism of action: a new class of drug for non-Hodgkin's lymphoma
Abdul Shukkur Ebrahim, Mustapha Kandouz, Allison Liddane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2002
Bcl-2 antisense oligonucleotides are effective against systemic but not central nervous system disease in severe combined immunodeficient mice bearing human t(14;18) follicular lymphoma
Ramzi Mohammad, Yousif Abubakr, Maria Dan, et al.
Molecular and Cellular Biology
|
August 27, 2014
Genomic uracil homeostasis during normal B cell maturation and loss of this balance during B cell cancer development
Sophia Shalhout, Dania Haddad, Angela Sosin, et al.
Page
of 4